Send us a text

Why aren't GLP-1 medications working for everyone?

You may be frustrated that semaglutide or tirzepatide isn't helping you lose weight like it has for others. The problem might not be your diet or willpower - it could be genetic.

Discover how a single gene called TCF7L2 may be sabotaging your weight loss efforts with GLP-1 medications, and what you can do about it.

BY THE TIME YOU FINISH LISTENING, YOU'LL DISCOVER:

• Why 10-15% of people may be "non-responders" to GLP-1 agonists for weight loss
• The gene that could impact the effectiveness of GLP-1
• Strategies to overcome genetic resistance to GLP-1 medications

This episode could be a game-changer if you've been struggling with weight loss despite using GLP-1 agonists.

RESEARCH ARTICLES:

1. Efficacy And Safety Of Semaglutide For Weight Loss In Adults With Overweight Or Obesity
2. A review of receptor interactions and co-stimulation, Peptides
3. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Support the show

LET'S KEEP THE CONVERSATION GOING

• Loved the episode? Screenshot and tag me @drtamarlawful I’d love to repost your takeaway!

WANT MORE SUPPORT ON YOUR HEALTH JOURNEY?

• Book your FREE Health & Wellness Consultation
• Learn how to safely use weight loss medications in Empowerment Hour
• Get a free sample nutrigenomics report
• Join our Facebook Community for support, accountability, and resources

PRACTITIONERS, COACHES & HEALTH PROFESSIONALS

• Join the Unlock the Blueprint Masterclass and learn how to Tailor nutrition, fitness & supplements for thriving wellness
• Want to refer clients or patients to us? Schedule a call

FOLLOW DR LAWFUL ON SOCIAL MEDIA

Instagram/LinkedIn/Tiktok: @drtamarlawful

E...